All News

Patient Access & Engagement

bluebird bio Receives Second FDA Approval for a Gene Therapy in Two Months with Skysona for CALD
20 September 2022
bluebird bio Receives Second FDA Approval for a Gene Therapy in Two Months with Skysona for CALD
bluebird bio’s Skysona has become
Can a Smaller Plasmid Produce Huge Benefits? The Power of Small
20 September 2022
Can a Smaller Plasmid Produce Huge Benefits? The Power of Small
Optimizing gene payload begins with
Capstan Therapeutics – Spin-Out from Penn University Launches with $165 Million to Deliver in vivo CAR-T
20 September 2022
Capstan Therapeutics – Spin-Out from Penn University Launches with $165 Million to Deliver in vivo CAR-T
Biotechnology company Capstan Therapeutics has
Phacilitate’s ATE Round-Up: People, Patients, and Possibilities
12 September 2022
Phacilitate’s ATE Round-Up: People, Patients, and Possibilities
In this blog we take
POPULAR NEWS ITEMS
Image
4 October 2022

AmplifyBio Acquires PACT Pharma to Advance Cell and Gene Therapy Services

Image
3 October 2022

Janssen Presents Positive Data from Two Ophthalmological Gene Therapy Programs

Image
22 September 2022

CAR-T Manufacturing Challenges and How to Overcome Them

Phacilitate’s ATE Plenary: Celebrating Science and Stripes
2 September 2022
Phacilitate’s ATE Plenary: Celebrating Science and Stripes
In this blog, we round-up
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
24 August 2022
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
bluebird bio has announced that
Scaling Clinical Cell and Gene Therapies
28 July 2022
Scaling Clinical Cell and Gene Therapies
In this webinar, discover how
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
21 June 2022
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

AmplifyBio Acquires PACT Pharma to Advance Cell and Gene Therapy Services

Image

Janssen Presents Positive Data from Two Ophthalmological Gene Therapy Programs

Image

CAR-T Manufacturing Challenges and How to Overcome Them